Literature DB >> 20374249

The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.

Stephanie R Shames1, Wanyin Deng, Julian A Guttman, Carmen L de Hoog, Yuling Li, Philip R Hardwidge, Ho Pan Sham, Bruce A Vallance, Leonard J Foster, B Brett Finlay.   

Abstract

Enterohaemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC respectively) are diarrhoeal pathogens that cause the formation of attaching and effacing (A/E) lesions on infected host cells. These pathogens encode a type III secretion system (T3SS) used to inject effector proteins directly into host cells, an essential requirement for virulence. In this study, we identified a function for the type III secreted effector EspZ. Infection with EPEC DeltaespZ caused increased cytotoxicity in HeLa and MDCK cells compared with wild-type EPEC, and expressing espZ in cells abrogated this effect. Using yeast two-hybrid, proteomics, immunofluorescence and co-immunoprecipitation, it was demonstrated that EspZ interacts with the host protein CD98, which contributes to protection against EPEC-mediated cytotoxicity. EspZ enhanced phosphorylation of focal adhesion kinase (FAK) and AKT during infection with EPEC, but CD98 only appeared to facilitate FAK phosphorylation. This study provides evidence that EspZ and CD98 promote host cell survival mechanisms involving FAK during A/E pathogen infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20374249     DOI: 10.1111/j.1462-5822.2010.01470.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  25 in total

1.  The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b.

Authors:  Stephanie R Shames; Matthew A Croxen; Wanyin Deng; B Brett Finlay
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

2.  Metalloprotease type III effectors that specifically cleave JNK and NF-κB.

Authors:  Kobi Baruch; Lihi Gur-Arie; Chen Nadler; Simi Koby; Gal Yerushalmi; Yinon Ben-Neriah; Orli Yogev; Eitan Shaulian; Chen Guttman; Raz Zarivach; Ilan Rosenshine
Journal:  EMBO J       Date:  2010-11-26       Impact factor: 11.598

3.  The secreted effector protein EspZ is essential for virulence of rabbit enteropathogenic Escherichia coli.

Authors:  John Scott Wilbur; Wyatt Byrd; Shylaja Ramamurthy; Hannah E Ledvina; Khaldoon Khirfan; Michael W Riggs; Edgar C Boedeker; Gayatri Vedantam; V K Viswanathan
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

4.  Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.

Authors:  Jennifer Lising Roxas; Katheryn Ryan; Gayatri Vedantam; V K Viswanathan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-06-05       Impact factor: 4.052

5.  Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.

Authors:  Ho Pan Sham; Stephanie R Shames; Matthew A Croxen; Caixia Ma; Justin M Chan; Mohammed A Khan; Mark E Wickham; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2011-07-11       Impact factor: 3.441

6.  Novel Host Proteins and Signaling Pathways in Enteropathogenic E. coli Pathogenesis Identified by Global Phosphoproteome Analysis.

Authors:  Roland Scholz; Koshi Imami; Nichollas E Scott; William S Trimble; Leonard J Foster; B Brett Finlay
Journal:  Mol Cell Proteomics       Date:  2015-05-05       Impact factor: 5.911

7.  Intestinal epithelial CD98 directly modulates the innate host response to enteric bacterial pathogens.

Authors:  Moiz A Charania; Hamed Laroui; Hongchun Liu; Emilie Viennois; Saravanan Ayyadurai; Bo Xiao; Sarah A Ingersoll; Daniel Kalman; Didier Merlin
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

Review 8.  Infection strategies of enteric pathogenic Escherichia coli.

Authors:  Abigail Clements; Joanna C Young; Nicholas Constantinou; Gad Frankel
Journal:  Gut Microbes       Date:  2012-03-01

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  The enteropathogenic Escherichia coli-secreted protein EspZ inhibits host cell apoptosis.

Authors:  Jennifer Lising Roxas; John Scott Wilbur; Xiangfeng Zhang; Giovanna Martinez; Gayatri Vedantam; V K Viswanathan
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.